Context: Identifying clusters (i.e., subgroups) of patients from the analysis of medico-administrative databases is particularly important to better understand disease heterogeneity. However, these databases contain different types of longitudinal variables which are measured over different follow-up periods, generating truncated data. It is therefore fundamental to develop clustering approaches that can handle this type of data.
Objective: We propose here cluster-tracking approaches to identify clusters of patients from truncated longitudinal data contained in medico-administrative databases.
Material And Methods: We first cluster patients at each age. We then track the identified clusters over ages to construct cluster-trajectories. We compared our novel approaches with three classical longitudinal clustering approaches by calculating the silhouette score. As a use-case, we analyzed antithrombotic drugs used from 2008 to 2018 contained in the Échantillon Généraliste des Bénéficiaires (EGB), a French national cohort.
Results: Our cluster-tracking approaches allow us to identify several cluster-trajectories with clinical significance without any imputation of data. The comparison of the silhouette scores obtained with the different approaches highlights the better performances of the cluster-tracking approaches.
Conclusion: The cluster-tracking approaches are a novel and efficient alternative to identify patient clusters from medico-administrative databases by taking into account their specificities.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jbi.2023.104309 | DOI Listing |
Cancers (Basel)
December 2024
Service de Biostatistiques et d'Information Médicale (DIM), CHU Dijon Bourgogne, 21000 Dijon, France.
Background: Recent publications suggest that the threshold for validation of the learning curve is 25 procedures. The aim of this study was to evaluate this threshold using another rarely used method, based on a composite quality indicator.
Methods: We included all patients from the French medico-administrative database receiving robot-assisted surgery for lung cancer, with a focus on hospitals performing at least 25 procedures over the period 2019-2022.
Joint Bone Spine
November 2024
AstraZeneca, Tour Carpe Diem, 31 Pl. des Corolles immatriculée, 92400 Courbevoie, France.
Objectives: Data on the economic consequences of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) are scarce in Europe. We aimed to estimate the total direct costs attributable to SLE and LN in France, at the nation-wide level.
Methods: Patients with SLE and LN were identified in the French nation-wide health insurance database (SNDS).
BMJ Open
November 2024
Department of General Medicine, University of Tours, Tours, Centre-Val de Loire, France.
Objectives: The first COVID-19 lockdown raised concerns about reduced access to primary care, especially for people with chronic diseases particularly at risk in the absence of follow-up. However, the COVIQuest trial, evaluating the impact of a general practitioner (GP) phone call (intervention) to chronic patients with cardiovascular disease (CVD) or mental health disorder (MHD) concluded that the intervention had no effect at 1 month on the rate of self-reported hospitalisations in the CVD subtrial, whereas the intervention group in MHD subtrial might have a higher rate. This second part of the study aimed to describe the 6 month hospitalisation and specialised consultation rates, using the French health data system ().
View Article and Find Full Text PDFJoint Bone Spine
November 2024
Department of Rheumatology, National Reference Center for Autoimmune Diseases (RESO), hôpitaux universitaires de Strasbourg, Inserm UMR-S 1109, Strasbourg, France. Electronic address:
Objectives: To investigate the risk and predictors of severity and mortality of COVID-19 infection in patients with Connective Tissue Diseases (CTDs).
Methods: Using the French nationwide claims and hospitalization database, we assembled a nation-wide exhaustive cohort of adult CTD patients with rheumatoid arthritis, systemic lupus, Sjögren's disease, inflammatory myopathies, systemic sclerosis. We analyzed the rates of hospitalization, severe inpatient stays (intensive care unit [ICU] admissions or in-hospital mortality), and in-hospital mortality with COVID-19 from January 1st to December 31st, 2020.
HPB (Oxford)
January 2025
Université de Lille, 42 rue Paul Duez, 59000, Lille, France; Department of digestive Surgery and Transplantation, CHRU de Lille, 2 Av. Oscar Lambret, 59000, Lille, France.
Background: The use of 1-year mortality following pancreatectomy for PDAC as a measure of surgical quality has not been evaluated. We aim to i) assess the 1-year mortality rate following pancreatectomy for PDAC, and ii) identify patient and hospital characteristics associated with 1-year mortality.
Methods: Data was extracted retrospectively from the French national medico-administrative database.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!